Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic...

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York...

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )

JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma

Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA

JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )

The past, present and future of treating ovarian cancer

Dr Susana Banerjee - The Institute of Cancer Research, London, UK

The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )

Comment on SOLO-1 for advanced ovarian cancer

Dr Jonathan Ledermann - University College London, London, UK

Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )

Olaparib improves progression free survival up front in ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA

Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )

A novel bifunctional fusion protein for combatting lung cancer

Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain

A novel bifunctional fusion protein for combatting lung cancer ( Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain )

Comment on new treatment options for breast cancer

Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany

Comment on new treatment options for breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )

Early stage trials in immunotherapy and brain screening

Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Early stage trials in immunotherapy and brain screening ( Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1

Prof Fabrice André - Institut Gustave Roussy, Paris, France

Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1 ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )

Results from the IMpassion130 trial for triple-negative breast cancer

Prof Peter Schmid - St Bartholomew Hospital London, UK

Results from the IMpassion130 trial for triple-negative breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )

Economics and education around biosimilars

Prof Arnold G. Vulto - Erasmus MC, Rotterdam, Netherlands

Economics and education around biosimilars ( Prof Arnold G. Vulto - Erasmus MC, Rotterdam, Netherlands )

PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer

Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA

PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer ( Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA )

More from ecancer